| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
5.00(B) |
| Last
Volume: |
262,995 |
Avg
Vol: |
492,576 |
| 52
Week Range: |
$71.24 - $95.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,305 |
2,305 |
24,823 |
94,111 |
| Total Sell Value |
$218,975 |
$218,975 |
$2,201,702 |
$7,357,280 |
| Total People Sold |
1 |
1 |
4 |
9 |
| Total Sell Transactions |
1 |
1 |
7 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jesse Sandra |
EVP and Chief Legal Officer |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$33 |
D/D |
3,323 |
17,971 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$63 |
D/D |
6,255 |
44,443 |
|
- |
|
| Selman Byron |
President, Global Markets |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$39 |
D/D |
3,909 |
10,902 |
|
- |
|
| Davies Kent J |
Chief Operating Officer |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$98 |
D/D |
9,774 |
16,314 |
|
- |
|
| Ryding Neil 122-62-507 |
EVP, Global Manufacturing |
• • – |
2015-10-20 |
4 |
A |
$0.01 |
$42 |
D/D |
4,222 |
4,222 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-09-15 |
4 |
AS |
$35.15 |
$230,900 |
D/D |
(6,569) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-09-15 |
4 |
OE |
$27.69 |
$181,896 |
D/D |
6,569 |
153,609 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-09-01 |
4 |
AS |
$35.63 |
$169,792 |
D/D |
(4,765) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-09-01 |
4 |
OE |
$27.28 |
$129,965 |
D/D |
4,765 |
151,805 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-08-20 |
4 |
AS |
$38.49 |
$188,688 |
D/D |
(4,902) |
38,188 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-08-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-08-17 |
4 |
AS |
$39.28 |
$258,019 |
D/D |
(6,569) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-08-17 |
4 |
OE |
$27.69 |
$181,863 |
D/D |
6,569 |
153,609 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-08-03 |
4 |
AS |
$39.91 |
$190,189 |
D/D |
(4,765) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-08-03 |
4 |
OE |
$27.28 |
$129,965 |
D/D |
4,765 |
151,805 |
|
- |
|
| Davies Kent J |
President, Global Markets |
• – – |
2015-07-23 |
4 |
S |
$39.36 |
$10,981 |
D/D |
(279) |
6,540 |
|
- |
|
| Fusco David |
EVP, Global Human Resources |
• – – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,679 |
2,679 |
|
- |
|
| Merriman Ronald |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
16,442 |
|
- |
|
| Meelia Richard J |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
16,880 |
|
- |
|
| Kroll Mark W |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
16,732 |
|
- |
|
| Zane Ellen M |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
11,128 |
|
- |
|
| Granadillo Pedro P |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
21,632 |
|
- |
|
| Dockendorff Charles J |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
7,153 |
|
- |
|
| Burns Brian R |
EVP, Global QA/RA |
• – – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,103 |
11,810 |
|
- |
|
| Gelbman Ronald G |
Director |
– • – |
2015-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,337 |
49,525 |
|
- |
|
1312 Records found
|
|
Page 19 of 53 |
|
|
1.16 (1.21%) 
